Abstract Details

Title Lack of Lymphopenia Following First Phase of Treatment with Alemtuzumab

Topic Multiple Sclerosis

Presentation(s) P5 - (-)

Poster/Presentation
Number 377

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Joshua Stone, MD (Southcoast Health) PRESENTER	No disclosure on file
Jonathan Cahill, MD, FAAN (Brown Neurology)	The institution of Dr. Cahill has received research support from Roche / Genentech. Dr. Cahill has received publishing royalties from a publication relating to health care.
Syed Rizvi, MD (Neurology Foundation)	Dr. Rizvi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono Roche Bristol Myers . Dr. Rizvi has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Na.

��ɫ����